ArticleBioinformatics (Oxford, England)2026
AutoHMD: scalable and accurate validation of antibody-antigen complexes by heated molecular dynamics.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationAntibody-antigen (Ab-Ag) interactions are central to immune recognition and widely exploited in therapeutic design, making accurate structural characterization of these complexes a central challenge in the field. While docking and artificial intelligence-based approaches can generate multiple candidate binding modes, reliably identifying near-native conformations represent a key bottleneck. Existing methods depend largely on static scoring functions, which fail to capture the dynamic nature of Ab-Ag interfaces and, as a result, offer limited power to discriminate between competing poses.
resultsHere, we evaluate heated molecular dynamics (HMD) as a strategy to discriminate binding pose quality based on structural stability under thermal perturbation, implemented through the automated workflow AutoHMD. Across a diverse set of Ab-Ag complexes, HMD enabled clear separation between high-quality and incorrect poses. During simulations, near-native complexes maintained a stable interface, whereas incorrect ones showed progressive divergence, particularly at elevated temperatures. Interaction analysis revealed that high-quality poses maintain more stable and persistent interfacial contacts throughout the simulations. In contrast, incorrect poses display an unstable interaction network. Additional simulation replicates increased classification consistency, while a mean iRMSD cutoff of approximately 2.5 Å achieved 90% accuracy in cross-validation and retained robust performance on an independent external set. Its transfer to Boltz-2-generated complexes further supported the broader applicability of HMD to AI-predicted binding poses. Overall, AutoHMD provides a reproducible, scalable, and high-throughput framework for validation of predicted antibody-antigen complexes, with potential applications in structural bioinformatics and biopharmaceutical design.
Indexed as
Identifiers
42853673What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.